An in-hospital clinical trial assessing nebulized lidocaine compared to saline for treatment of asthma in horses
Journal of Veterinary Internal Medicine · 2026
DOI: 10.1093/jvimsj/aalaf053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2026. Verfasst von Ananya Mahalingam-Dhingra und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, MA 01536, United States. Hauptthemen laut MEDLINE: Anesthetics, Local, Asthma, Horse Diseases, Lidocaine. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Grayson-Jockey Club Research Foundation.
Abstract (Originalsprache)
Background
Corticosteroids are the main pharmacologic treatment for equine asthma (EA) but may have adverse effects in metabolically unstable horses. Recent pilot studies support the use of nebulized lidocaine as an alternative treatment option. Hypothesis/Objectives Nebulized lidocaine will improve EA-associated clinical variables and airway inflammation. Animals Twenty client-owned horses diagnosed with EA.
Methods
Randomized, blinded, in-hospital study comparing 1 mg/kg preservative-free 4% lidocaine (n = 10) nebulized via Flexineb (twice daily for 7 doses) to 0.9% saline control (n = 10). Clinical examination, endoscopy, lung function, bronchoalveolar lavage (BAL) cytology, and inflammatory cytokines in blood and epithelial lining fluid (ELF) were compared between treatment groups using univariate analyses. Global linear models were used to assess covariate impact (P < .05).
Results
The effect of treatment on clinical variables (clinical score, lung function, mucus, and BAL cytology) did not differ between saline and lidocaine treated horses. However, the severity of EA as a covariate significantly impacted multiple baseline variables and confounded the effect of treatment type. Saline-treated horses showed significantly larger decreases in ELF tissue necrosis factor alpha (P = .04) and interferon gamma concentrations (P = .03), compared with lidocaine-treated horses, independent of covariates. Conclusions and clinical importance We did not identify a difference in treatment effect of nebulized lidocaine compared to saline on clinical variables in hospitalized asthmatic horses. A longer duration of lidocaine administration or focus on severe EA may be necessary to establish treatment effects. Observed changes in lower airway cytokine concentrations suggest that saline may have more than a placebo effect in treating EA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, MA 01536, United States.
- Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
ORCID-Profile: Daniela Bedenice, Melissa R Mazan
Förderung
- Grayson-Jockey Club Research Foundation
Zitieren
APA
Mahalingam-Dhingra, A., Bedenice, D., South, A., Minuto, J., Robins, T. J., Trautwein, V., Larkin, M., Wagner, B., & Mazan, M. R. (2026). An in-hospital clinical trial assessing nebulized lidocaine compared to saline for treatment of asthma in horses. Journal of Veterinary Internal Medicine. https://doi.org/10.1093/jvimsj/aalaf053
Vancouver
Mahalingam-Dhingra A, Bedenice D, South A, Minuto J, Robins TJ, Trautwein V, et al. An in-hospital clinical trial assessing nebulized lidocaine compared to saline for treatment of asthma in horses. Journal of Veterinary Internal Medicine. 2026. doi:10.1093/jvimsj/aalaf053
BibTeX
@article{MahalingamDhingra2026,
author = {Mahalingam-Dhingra, Ananya and Bedenice, Daniela and South, Adam and Minuto, Jillian and Robins, Tyler-Jane and Trautwein, Victoria and Larkin, Melissa and Wagner, Bettina and Mazan, Melissa R},
title = {An in-hospital clinical trial assessing nebulized lidocaine compared to saline for treatment of asthma in horses},
journal = {Journal of Veterinary Internal Medicine},
year = {2026},
doi = {10.1093/jvimsj/aalaf053}
}
EUVIMED